Display options
Cite
Allegretti JR, Fischer M, Sagi SV, et al. Correction to: Fecal Microbiota Transplantation Capsules with Targeted Colonic Versus Gastric Delivery in Recurrent Clostridium difficile Infection: A Comparative Cohort Analysis of High and Low Dose. Dig Dis Sci. 2019;64(7):2059doi: 10.1007/s10620-019-05527-4.
Allegretti, J. R., Fischer, M., Sagi, S. V., Bohm, M. E., Fadda, H. M., Ranmal, S. R., Budree, S., Basit, A. W., Glettig, D. L., de la Serna, E. L., Gentile, A., Gerardin, Y., Timberlake, S., Sadovsky, R., Smith, M., & Kassam, Z. (2019). Correction to: Fecal Microbiota Transplantation Capsules with Targeted Colonic Versus Gastric Delivery in Recurrent Clostridium difficile Infection: A Comparative Cohort Analysis of High and Low Dose. Digestive diseases and sciences, 64(7), 2059. https://doi.org/10.1007/s10620-019-05527-4
Allegretti, Jessica R, et al. "Correction to: Fecal Microbiota Transplantation Capsules with Targeted Colonic Versus Gastric Delivery in Recurrent Clostridium difficile Infection: A Comparative Cohort Analysis of High and Low Dose." Digestive diseases and sciences vol. 64,7 (2019): 2059. doi: https://doi.org/10.1007/s10620-019-05527-4
Allegretti JR, Fischer M, Sagi SV, Bohm ME, Fadda HM, Ranmal SR, Budree S, Basit AW, Glettig DL, de la Serna EL, Gentile A, Gerardin Y, Timberlake S, Sadovsky R, Smith M, Kassam Z. Correction to: Fecal Microbiota Transplantation Capsules with Targeted Colonic Versus Gastric Delivery in Recurrent Clostridium difficile Infection: A Comparative Cohort Analysis of High and Low Dose. Dig Dis Sci. 2019 Jul;64(7):2059. doi: 10.1007/s10620-019-05527-4. PMID: 30778870.
Copy Download .nbib Format: NLM
Share it on

Dig Dis Sci. 2019 Jul;64(7):2059. doi: 10.1007/s10620-019-05527-4.

Correction to: Fecal Microbiota Transplantation Capsules with Targeted Colonic Versus Gastric Delivery in Recurrent Clostridium difficile Infection: A Comparative Cohort Analysis of High and Low Dose.

Digestive diseases and sciences

Jessica R Allegretti, Monika Fischer, Sashidhar V Sagi, Matthew E Bohm, Hala M Fadda, Sejal R Ranmal, Shrish Budree, Abdul W Basit, Dean L Glettig, Eva L de la Serna, Amanda Gentile, Ylaine Gerardin, Sonia Timberlake, Rotem Sadovsky, Mark Smith, Zain Kassam

Affiliations

  1. Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women's Hospital, 75 Francis Street, Boston, MA, 02115, USA. [email protected].
  2. Harvard Medical School, Boston, MA, USA. [email protected].
  3. Division of Gastroenterology, Indiana University, Indianapolis, IN, USA.
  4. College of Pharmacy and Health Sciences, Butler University, Indianapolis, IN, USA.
  5. Intract Pharma, London, UK.
  6. OpenBiome, Somerville, MA, USA.
  7. University of Cape Town, Cape Town, South Africa.
  8. School of Pharmacy, University College London, London, UK.
  9. Finch Therapeutics, Somerville, MA, USA.

PMID: 30778870 DOI: 10.1007/s10620-019-05527-4

Abstract

The original version of the article unfortunately contained an error in article title. The corrected title is 'Fecal Microbiota Transplantation Capsules with Targeted Colonic Versus Gastric Delivery in Recurrent Clostridium difficile Infection: A Comparative Cohort Analysis of High and Low Dose'.

Publication Types